Compare ECVT & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ECVT | CNMD |
|---|---|---|
| Founded | 1935 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2017 | 1995 |
| Metric | ECVT | CNMD |
|---|---|---|
| Price | $14.08 | $39.74 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 6 |
| Target Price | $14.00 | ★ $48.00 |
| AVG Volume (30 Days) | ★ 2.7M | 357.1K |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.04% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.51 |
| Revenue | $723,515,000.00 | ★ $1,374,724,000.00 |
| Revenue This Year | $26.96 | $0.82 |
| Revenue Next Year | $5.71 | $5.48 |
| P/E Ratio | ★ N/A | $25.49 |
| Revenue Growth | 2.70 | ★ 5.18 |
| 52 Week Low | $5.68 | $33.21 |
| 52 Week High | $14.42 | $60.80 |
| Indicator | ECVT | CNMD |
|---|---|---|
| Relative Strength Index (RSI) | 69.91 | 60.87 |
| Support Level | $8.17 | $39.36 |
| Resistance Level | N/A | $46.08 |
| Average True Range (ATR) | 0.47 | 1.58 |
| MACD | 0.10 | 0.68 |
| Stochastic Oscillator | 77.27 | 99.56 |
Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has one operating segment. The Company's single reportable segment, Ecoservices, derives its revenue through the sale of virgin and regenerated sulfuric acid products and services.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.